Merck
CN
高级检索
结构检索
Search Within
文件类型

95-92-1

应用筛选条件
关键词:'95-92-1'
显示 1-30 共 442 条结果 关于 "95-92-1" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
76 104 96 98 89 PKA 2 91 35 17 94 95 105 106 96 66 97 91 104 104 96 96 70 99 87 PKCα 79 98 86 95 95 92 99 93 89 92 100 91
The Effective Use of Protein Kinase Inhibitors
76 104 96 98 89 PKA 2 91 35 17 94 95 105 106 96 66 97 91 104 104 96 96 70 99 87 PKCα 79 98 86 95 95 92 99 93 89 92 100 91
High throughput sample preparation for the quantitation of drug compounds in serum samples
Plate #1 Plate #2 Plate #3 Plate #4 Digoxin 93±3% 96±2% 98±3% 94±1% Propranolol 97±2% 98±4% 95±3% 96±2% Taxol 93±3% 92±1% 91±2% 88±2% Testosterone 94±3% 92±2% 91±2% 90±1% Verapamil 95±3% 97
Poster: Purification with Millipore MultiScreen 384SEQ Plates on Beckman-Coulter’s Biomek FX for High Quality Direct Sequencing in High-Throughput Genomics
97% Ifnar2_3 zq 42.31 408.01 92% ifnar2_3 yq 43.09 445.2 98% Ifnar2_3 zq 39.38 383.49 95% Ifnar2_3 yq 35.12 298.71 94% ifnar2_3 zq 38.5 352.94 90% Ifngr2_2 yq 39.24 332.17 95% Ifngr2_2 yq 40.1 338.87 89%
Product Information Sheet-dntpm-ro
Pre-Incubation 92 – 95(1) 2 min 1 Denaturation Annealing Elongation 92 – 95(1) 55 – 65(2) 72(3) 15 – 30 sec 30 – 60 sec 45 sec – 3 min 10 Denaturation Annealing Elongation
MMP Activation Chart
Matrix Supp 1. 245, Okada, JBC267/'92/21712 activeMMP-7 1:1 37oC, 4h 83 & 80 78 74.6* L 16RTNL; C-term cleavage 0.25x Imai, jbc270/1995/6691 APMA, 1mM + activeMMP-7 (1:1) 37oC, 12h
DECLARATION OF CONFORMITY Benchmark MyBlock Digital Drybath
Low Voltage Directive 2006/95/EC
DECLARATION OF CONFORMITY -Benchmark MultiTherm Shaker
Low Voltage Directive 2006/95/EC
Product Information Sheet-03734927001
Pre-Incubation 92 – 95(1) 2 min 1 Denaturation Annealing Elongation 92 – 95(1) 55 – 65(2) 72 15 – 30 sec 30 – 60 sec 45 sec – 3 min 10 Denaturation Annealing Elongation
Application Note – N-Boc deprotection
93% N H N Cbz 97% N H N OH 95% HO NH2 95% HO O NH2 92% TsOH TsOH TsOH TsOH TsOH TsOH TsOH TsOH 1/2TsOH TsOH
Quality Control Range Sheet- MCC-115 and MCC-215
Control 1 92 - 209 pg/mL Control 2 463 - 962 pg/mL Control 2 1970 - 4337 pg/mL Control 2 400 - 1184 pg/mL M-CSF Control 1 94 - 194 pg/mL
Quality Control Ranges: Human Angiogenesis/ Growth Factor Magnetic Bead Panel 1
G-CSF Control 1 227 – 472 pg/mL HB-EGF Control 1 22 – 46 pg/mL Control 2 970 – 2015 pg/mL Control 2 90 – 187 pg/mL
Data Sheet - SRP5171
thaw cycles. Figure 1. SDS-PAGE Gel of Typical Lot 70–95% (densitometry) 34 43 72 95 130 170 56 αCa tenin 26 References 1. Rimm, D.L. et al., Alpha 1(E)-catenin is an actin
Data Sheet - SRP5203
multiple freeze/thaw cycles. Figure 1. SDS-PAGE Gel of Typical Lot 70–95% (densitometry) LC20 34 43 72 95 130 170 56 26 17 References 1. Wagner, P.D. et al., Regulation of
RABBIT ANTI-OREXIN-B POLYCLONAL ANTIBODY
2003) 6:103-111. RELATED REFERENCES: Sakurai, T et al. (1998) Cell. 92:573-585. DeLecca, L et al. (1998) PNAS. 95:322-327. Important Note: During shipment, small volumes of product
Data Sheet - SRP5142
imidazole, 0.1 mM PMSF, 0.25 mM DTT, and 25% glycerol. Molecular mass: ∼92 kDa Purity: 70–95% (SDS-PAGE, see Figure 1) Precautions and Disclaimer This product is for R&D use only, not for drug
SARS-COV-2-Spike-RBD epitope (480-499)
Recommended thawing solution: Water. References 1. García, Luis F., Frontiers in immunology, 11: 1441 (2020). 2. Walls AC, et al., Cell. 181:281–92.e6 (2020). 3. Shang J., et al., Nature. 581:221
SARS-COV-2-Spike-RBD epitope (450-469)
Recommended thawing solution: Water. References 1. García, Luis F., Frontiers in immunology, 11: 1441 (2020). 2. Walls AC, et al., Cell. 181:281–92.e6 (2020). 3. Shang J., et al., Nature. 581:221
Data Sheet - C9618
by titration. References 1. Watt, S.M., et al., Blood, 92, 849-866 (1998). 2. Doyonnas, R., et al., J. Immunol., 165, 840-851 (2000). 3. Watt, S.M., et al., Blood, 95, 3113-3124 (2000). 4. Watt
Data Sheet - SRP5112
mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, and and 25% glycerol. Molecular mass: ∼92 kDa Purity: 70–95% (SDS-PAGE, see Figure 1) Precautions and Disclaimer This product is for R&D use only, not for drug
Data Sheet - SAB4200698
determining optimal working concentration by titration test. References 1. Minamino, N., et al., Clin. Hemorheol. Microcirc., 23, 95-102 (2000). 2. Artunc F., et al., PLoS One, 9, e86148 (2014). 3. Gouya
Data Sheet - R6634
Kessler, C., et al., Gene, 92, 1 1990. 8/99 Sigma brand products are sold through Sigma-Aldrich, Inc. Sigma-Aldrich, Inc. warrants that its products conform to the information contained in this and other
Data Sheet - R2634
Kessler, C., et. al., Gene, 92, 1 (1990). 10/99 Sigma brand products are sold through Sigma-Aldrich, Inc. Sigma-Aldrich, Inc. warrants
Data Sheet - SRP5054
.1 mM PMSF, and 25% glycerol. Molecular mass: ∼110 kDa Purity: 70–95% (SDS-PAGE, see Figure 1) Specific Activity: 68–92 nmole/min/mg (see Figure 2) Precautions and Disclaimer This product
Data Sheet - P3118
recommend determining the optimal working dilutions by titration. References 1. Barroso, M., et al., Proc. Natl. Acad. Sci. USA, 92, 527-531 (1995). 2. Nelson, D.S., et al., J. Cell Biol., 143, 319-331
Data Sheet - S5933
at least 10 µg/ml using A431 cells fixed with 95% ethanol and 5% acetic acid. By immunoprecipitation, 4 µg will immunoprecipitate STAT3 from 0.5-1 mg of an EGF stimulated human A431 cell lysate.
Verfication summary-03-0202-00
6.9 5% 92% 3 1:16 8.17 0.4 5% 130.65 6.1 5% 92% 3 1:32 4.69 0.2 4% 150.01 5.8 4% 105% HMN713787 2 MRD (1:4) 45.07 4.9 11% 180.27 19.7 11% - 3 1:8 20.18 2.1
Verfication summary-03-0202-00
6.9 5% 92% 3 1:16 8.17 0.4 5% 130.65 6.1 5% 92% 3 1:32 4.69 0.2 4% 150.01 5.8 4% 105% HMN713787 2 MRD (1:4) 45.07 4.9 11% 180.27 19.7 11% - 3 1:8 20.18 2.1
RAT OREXIN 1 RECEPTOR CONTROL PEPTIDE
repeated freeze/thaw cycles. RELATED REFERENCES: 1. Sakurai, T et al. (1998) Cell. 92:573-585. 2. DeLecca, L et al. (1998) PNAS. 95:322-327. Important Note: During shipment, small volumes
Development of Multiplex Immunoassay Panels for Simultaneous Quantification of Bone Metabolism Markers using Luminex xMAP Technology
Panels: 2 Multiplex and 1 Single-plex ACCURACY (%): 1A 1B 2A 2B RANKL — — 119 78 OPG 95 90 — — Insulin 92 101 92 91 Leptin 87 93 93 93 ACTH 117 92 115 85 IL-6 86 87 89 90 TNFα 122 92
1/15